proprotein convertase subtilisin/kexin type 9 [gngm]
Inhibition [menp]
Forward [spco]
treatment [ftcn]
Dyslipidaemia [dsyn]
Decade [qnco]
Discovery [acty]
Gene [gngm]
Encoding [idcn]
proprotein convertase subtilisin/kexin type 9 [gngm]
Recognition [menp]
cholesterol metabolism [moft]
proprotein convertase subtilisin/kexin type 9 [gngm]
Inhibition [menp]
Now [tmco]
considered [idcn]
Approach [spco]
reduction [npop]
Residual [qlco]
Cardiovascular disease [dsyn]
progress [ftcn]
proprotein convertase subtilisin/kexin type 9 [gngm]
Discovery [acty]
Targeted [ftcn]
treatment [ftcn]
Scale [medd]
Speed [qnco]
Suggestion [idcn]
Link [inpr]
proprotein convertase subtilisin/kexin type 9 [gngm]
Hypercholesterolaemia [dsyn]
Published [ocac]
Decade [qnco]
meta-analyses [resa]
Clinical Trials [resa]
proprotein convertase subtilisin/kexin type 9 [gngm]
treatment [ftcn]
placebo [topp]
ezetimibe [orch, phsu]
Including [ftcn]
Published [ocac]
Currently [tmco]
proprotein convertase subtilisin/kexin type 9 [gngm]
inhibitors [chvf]
Evaluated [ftcn]
Clinical Trials [resa]
Future [tmco]
Lipid-lowering therapy [topp]
establishing [qlco]
Efficacy [qlco]
Cardiovascular event [fndg]
reduction [npop]
Safety [hcpp]
consequences [ftcn]
Prolonged [tmco]
Exposure NOS [inpo]
Very low [fndg]
Levels [qlco]
Cholesterol, LDL [bacs, strd]
Rapid [qlco]
Drugs [phsu]
Novel [tmco]
technologies [ocdi]
GENETIC [topp]
Validation [resa]
Rapid progression [fndg]
Tool [mnob]
Drugs [phsu]
